Friday, July 24, 2026
Advertisement
Home Healthcare Markets Business Sensyne explores dual listing in the US

Sensyne explores dual listing in the US

By
Maria Davies
-
Sensyne Health CEO Paul Drayson
Paul Drayson, CEO, Sensyne Health

Clinical AI company Sensyne Health has announced plans to explore a dual listing on NASDAQ. The company, which was founded by former science minister and CEO Lord Paul Drayson and listed on AIM in 2018, said the dual listing was among a number of options being considered as it continued to explore strategic growth opportunities…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?

RELATED ARTICLESMORE FROM AUTHOR

Stay ahead of the market

Get the essential stories, market movements and analysis from across the UK independent healthcare and social care sector – every week.

  • Expert analysis and market intelligence
  • Curated independent healthcare and social care news
  • Delivered weekly to your inbox

Join our weekly newsletters

  • HealthcareMarkets
  • CareMarkets
Sign up now

Join thousands of sector professionals

LaingBuisson News

About LaingBuisson

LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]

Follow LaingBuisson

Linkedin Mail RSS Soundcloud X Youtube
©2026 All rights reserved LaingBuisson
MORE STORIES

InHealth reports flat revenue as CDC expansion dents margins

Business

Transactions in care home market continue to build, data shows

News

Government considering New Zealand-style tenure model

News